Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer
Akanksha Khandelwal, Uttam Sharma, Tushar Singh Barwal, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection
Hardeep Singh Tuli, Vivek Kumar Garg, Sakshi Bhushan, et al.
Translational Oncology (2022) Vol. 27, pp. 101596-101596
Open Access | Times Cited: 48
PI3K/AKT pathway as a pivotal regulator of epithelial-mesenchymal transition in lung tumor cells
Meysam Moghbeli
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer
Cuiliu Liu, Xiaoqiang Xiang, Shuangqing Han, et al.
Cancer Letters (2021) Vol. 524, pp. 91-102
Closed Access | Times Cited: 49
The regulatory role of autophagy-related miRNAs in lung cancer drug resistance
Mahshid Shahverdi, Khalil Hajiasgharzadeh, Amin Daei Sorkhabi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112735-112735
Open Access | Times Cited: 34
Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021
Chunyan Zhang, Caifang Sun, Yabin Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11389-11389
Open Access | Times Cited: 33
MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
Javaid Ahmad Wani, Sabhiya Majid, Zuha Imtiyaz, et al.
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1610-1610
Open Access | Times Cited: 25
MicroRNAs modulation in lung cancer: exploring dual mechanisms and clinical prospects
Shahid Hussain, Habib Bokhari, Xing‐Xing Fan, et al.
Biocell (2024) Vol. 48, Iss. 3, pp. 403-413
Open Access | Times Cited: 6
Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck cancer
Yu‐Li Lo, Hua-Ching Lin, Wei‐Hsuan Tseng
Acta Biomaterialia (2022) Vol. 153, pp. 465-480
Closed Access | Times Cited: 17
MicroRNA 320a-3p up-regulation reduces PD-L1 expression in gastric cancer cells: an experimental and bioinformatic study
Vahid Asghariazar, Shima Makaremi, Noorhan Amani, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Analysis of miR-375-3p, miR-197-3p, and miR-15a-5p Expression and Their Clinical Relevance as Biomarkers in Lung Cancer
Sachin Kumar, Jyoutishman Saikia, Surender K. Sharawat, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 15
LINC00324 promotes cell proliferation and metastasis of esophageal squamous cell carcinoma through sponging miR-493-5p via MAPK signaling pathway
Uttam Sharma, Manjit Kaur Rana, Karuna Singh, et al.
Biochemical Pharmacology (2022) Vol. 207, pp. 115372-115372
Closed Access | Times Cited: 15
Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients
Justyna Raczkowska, Agnieszka Bielska, Adam Krętowski, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
MiRNAs and Microbiota in Non-Small Cell Lung Cancer (NSCLC): Implications in Pathogenesis and Potential Role in Predicting Response to ICI Treatment
Francesco Nucera, Paolo Ruggeri, Calogera Claudia Spagnolo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6685-6685
Open Access | Times Cited: 3
Crocin exerts anti-proliferative and apoptotic effects on cutaneous squamous cell carcinoma via miR-320a/ATG2B
Xiaoqing Bi, Zhenjuan Jiang, Zhaohui Luan, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 4569-4580
Open Access | Times Cited: 19
MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation
Richard E. Frye, Shannon Rose, Sandra McCullough, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 9, pp. 922-922
Open Access | Times Cited: 17
Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer
Yanting Wang, Tao Zhang, Xin He
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
The novel miR-873-5p-YWHAE-PI3K/AKT axis is involved in non-small cell lung cancer progression and chemoresistance by mediating autophagy
Li Z, Jinglei Liu, Ping Wang, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 2
Closed Access | Times Cited: 2
Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis
Neena George, Poonam Bhandari, Padival Shruptha, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 11, pp. 2581-2606
Open Access | Times Cited: 5
Selection of endogenous control and identification of significant microRNA deregulations in cervical cancer
Tereza Stverakova, Ivana Baranová, Petra Sauer Mikyskova, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Ampelopsin targets in cellular processes of cancer: Recent trends and advances
Hardeep Singh Tuli, Katrin Sak, Vivek Kumar Garg, et al.
Toxicology Reports (2022) Vol. 9, pp. 1614-1623
Open Access | Times Cited: 7
MiR-320a upregulation contributes to the effectiveness of pemetrexed by inhibiting the growth and invasion of human lung cancer cell line (Calu-6)
Akbar Ghorbani Alvanegh, Ayyoob Arpanaei, Hadi Esmaeili Gouvarchin Ghaleh, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Combining serum microRNAs and machine learning algorithms for diagnosing infectious fever after HSCT
Wenwei Shao, Yixuan Wang, Liu L, et al.
Annals of Hematology (2024) Vol. 103, Iss. 6, pp. 2089-2102
Closed Access | Times Cited: 1
A predictive model for prognostic risk stratification of early-stage NSCLC based on clinicopathological and miRNA panel
Lisha Ying, Tingting Lü, Yiping Tian, et al.
Lung Cancer (2024) Vol. 195, pp. 107902-107902
Closed Access | Times Cited: 1
The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer
Ritu Yadav, Rinku Khatkar, Kenneth C-H Yap, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Peritoneal Fluid Analysis of Advanced Ovarian Cancers after Hyperthermic Intraperitoneal Chemotherapy
Wei‐Chun Chen, Ting‐Chang Chang, Hung‐Hsueh Chou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9748-9748
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top